Table 2.
Current comorbid diagnoses and psychotropic medications of the MDD participants
| Participants | % of total | |
|---|---|---|
| Comorbidities |
7 |
50 |
| Social phobia |
4 |
28.6 |
| General anxiety disorder |
3 |
21.4 |
| Panic disorder |
2 |
14.3 |
| Post-traumatic stress disorder |
2 |
14.3 |
| Specific phobia |
2 |
14.3 |
| Bulimia nervosa |
1 |
7.1 |
| Psychiatric medications |
3 |
21.4 |
| Aripiprazole |
2 |
14.3 |
| Duloxetine |
1 |
7.1 |
| Gabapentin |
1 |
7.1 |
| Quetiapine |
1 |
7.1 |
| Sertraline |
1 |
7.1 |
| Venlafaxine | 1 | 7.1 |
MDD major depressive disorder.